Objective
to report the adverse clinical outcomes of 6-month DAPT compared to 12 month DAPT
Study
multicentre, non-inferiority randomised trial
Population
patients receiving drug-eluting coronary stents
Endpoints
target vessel failure as composite of cardiac death, MI, or ischaemia-driven target vessel revascularisation at 12 months


Conclusion
Six-month DAPT after DES was non-inferior to 12-month DAPT
Gwon et al. Circulation 2023; November